<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>To explore the relationship between T cell markers in <z:e sem="disease" ids="C0018939" disease_type="Disease or Syndrome" abbrv="">hematological diseases</z:e> and T cell markers in <z:e sem="disease" ids="C0280100" disease_type="Neoplastic Process" abbrv="">solid tumor</z:e>, CD3, CD4, CD8 in <z:e sem="disease" ids="C0018939" disease_type="Disease or Syndrome" abbrv="">hematological diseases</z:e>, malignant and <z:e sem="disease" ids="C0086692" disease_type="Neoplastic Process" abbrv="">benign tumors</z:e> were detected by flow cytometry and results were analyzed statistically </plain></SENT>
<SENT sid="1" pm="."><plain>The results showed that CD3, CD4, CD8 and CD4/CD8 in <z:hpo ids='HP_0005558'>chronic leukemia</z:hpo> decreased significantly while these markers in <z:hpo ids='HP_0002488'>acute leukemia</z:hpo> and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> decreased obviously in comparison with <z:mpath ids='MPATH_458'>normal</z:mpath> persons and other <z:e sem="disease" ids="C0018939" disease_type="Disease or Syndrome" abbrv="">hematological diseases</z:e> (P &lt; 0.0l) </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0001878'>Hemolytic anemia</z:hpo> markers increased significantly (P &lt; 0.05) </plain></SENT>
<SENT sid="3" pm="."><plain>CD3, CD4, CD4/CD8 in <z:hpo ids='HP_0001973'>idiopathic thrombocytopenic purpura</z:hpo> decreased and CD8 increased (P &lt; 0.0l) </plain></SENT>
<SENT sid="4" pm="."><plain>CD3, CD4, CD8 in <z:hpo ids='HP_0001891'>iron-deficiency anemia</z:hpo>, <z:hpo ids='HP_0001903'>anemia</z:hpo> from <z:hpo ids='HP_0011010'>chronic</z:hpo> diseases, <z:e sem="disease" ids="C0086692" disease_type="Neoplastic Process" abbrv="">benign tumor</z:e> and other <z:e sem="disease" ids="C0018939" disease_type="Disease or Syndrome" abbrv="">hematological diseases</z:e> were lower than those in <z:mpath ids='MPATH_458'>normal</z:mpath> persons and <z:hpo ids='HP_0001878'>hemolytic anemia</z:hpo>, but higher than those in <z:hpo ids='HP_0011009'>acute</z:hpo> and <z:hpo ids='HP_0005558'>chronic leukemia</z:hpo>, <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignant tumor</z:e>, <z:hpo ids='HP_0001913'>granulocytopenia</z:hpo>, and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> (P &gt; 0.05) </plain></SENT>
<SENT sid="5" pm="."><plain>It is notable that the above markers correlated with the development and prognosis of diseases </plain></SENT>
<SENT sid="6" pm="."><plain>In conclusion, expression of CD3, CD4, CD8, CD4/CD8 contributes to diagnosis of <z:e sem="disease" ids="C0018939" disease_type="Disease or Syndrome" abbrv="">hematological diseases</z:e> and benign or <z:mp ids='MP_0002018'>malignant tumors</z:mp>, and is an important indicator for therapeutic strategy </plain></SENT>
</text></document>